ATLANTA—A consortium of medical doctors has raised questions about the increasing number of cancer cases they’ve observed over the past five years, calling for more research to better understand the phenomenon and suggesting that a new approach to treatment is needed to address it.
The discussion took place at the Independent Medical Alliance conference in Atlanta, Georgia, over the weekend of April 4–6, during a panel discussion moderated by Jan Jekielek, senior editor for The Epoch Times and host of EpochTV’s “American Thought Leaders.”
“The concern is when you start looking at some of the urban data that’s out there,” Dr. Ray Page, an oncologist with 30 years of practice, said during the discussion. “Because in my personal experience, over the last few years during COVID, I saw some things that were occurring in my office when the vaccines started for COVID that in my 30 years of practice, it’s like, wow, that’s interesting. Never really seen that before.”
Page described the “strange phenomena,” including aggressive cancers and higher incidents of clotting, as particularly concerning and said that restoring immune systems to balanced states is of paramount importance.
“Because the bottom line, there’s nothing more powerful than turning on your natural immune system to kill the cancer,” Page said.
One leading cancer researcher told the hundreds of attendees—including many practicing medical professionals—that traditional treatment methods, such as radiotherapy and chemotherapy, fail to address the root cause of cancerous cells by eliminating the stem cells that allow them to form.
“So, not only does radiotherapy not kill the stem cells, it actually enhances the generation,” Dr. Paul Marik, chief medical officer for the medical alliance, said during the discussion. “If you don’t deal with the roots, you just crack down the trees, it’s going to grow back again.”
A doctor specializing in pathology said traditional medical literature fails to grasp the enormity and complexity of cancer, noting that the approximately eight billion people on the planet have, on average, between 30 trillion and 36 trillion individual cells.
“Do the math, so the textbooks hold that there are over 200 cancers. But given you as a unique individual and everybody on this planet, what’s the reality?” Dr. Ryan Cole said during the panel. “The number of cancers is actually incalculable.”
One colleague on the panel agreed and suggested that a novel approach to identifying and managing cancer is needed.
“Cancer is not one disease, it’s a million diseases and a million combinations, and it takes a very nuanced way to treat it,” Dr. Lynn Fynn said.
She said studies to explore the role of lipid nanoparticles—utilized as a delivery mechanism in the MRNA shots rolled out during the pandemic—could shed light on the prevalence of cancers some doctors are now reporting in young, healthy athletes and other individuals not generally thought to be at high risk of cancer.
“We’re seeing late-stage diagnosis of aggressive cancers that are a bit resistant to conventional therapies,” Fynn said. “The lipid nanoparticles themselves are highly inflammatory. Cancer is multifaceted, but inflammation is a common thread, universal. Unchecked inflammation in the body is a recipe for disaster.”
All four doctors on the panel recommended a holistic approach to health, which includes avoiding chemicals in the diet and eating “real food,” meaning foods that are free from heavy processing and what they described as questionable ingredients.
A return to the precautionary principle—an idea that any action or policy suspected of causing harm should be avoided until objective, supportive evidence is discovered through rigorous scientific study—was also highlighted as an important step for the medical field to take when considering new technologies or techniques to treat or prevent disease.
Restoring trust in medical research was a recurring theme of the discussion, with experts calling for a focus on objective, scientific study.
“The gold standard is a well-controlled, randomized trial, and without those controls, and without the proper gold standard for study, anyone can say whatever they want,” Fynn said. “But it costs money, and right now, with so much conflicted interest in clinical research, you’re only going to read what they want you to, the conclusion they want you to come to.”
